Healthcare provider profile · identity verified

Abigail Lewis, MD

Family Practice · WISCONSIN RAPIDS, WI · NPI 1366723751

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	843	238
Levothyroxine Sodium	Levothyroxine Sodium	695	173
Atorvastatin Calcium	Atorvastatin Calcium	584	155
Losartan Potassium	Losartan Potassium	511	149
Omeprazole	Omeprazole	501	136
Lisinopril	Lisinopril	490	133
Amlodipine Besylate	Amlodipine Besylate	446	130
Metformin Hcl Er	Metformin Hcl	427	122
Metoprolol Succinate	Metoprolol Succinate	420	112
Hydrochlorothiazide	Hydrochlorothiazide	410	104
Gabapentin	Gabapentin	283	46
Furosemide	Furosemide	277	76
Simvastatin	Simvastatin	262	65
Citalopram Hbr	Citalopram Hydrobromide	255	59
Eliquis	Apixaban	217	44
Metoprolol Tartrate	Metoprolol Tartrate	206	50
Albuterol Sulfate Hfa	Albuterol Sulfate	200	72
Jardiance	Empagliflozin	192	46
Sertraline Hcl	Sertraline Hcl	192	48
Alendronate Sodium	Alendronate Sodium	190	57
Potassium Chloride	Potassium Chloride	189	50
Ozempic	Semaglutide	177	33
Allopurinol	Allopurinol	176	44
Pravastatin Sodium	Pravastatin Sodium	174	49
Duloxetine Hcl	Duloxetine Hcl	146	30
Trazodone Hcl	Trazodone Hcl	142	41
Trulicity	Dulaglutide	141	28
Fluticasone Propionate	Fluticasone Propionate	137	63
Metformin Hcl	Metformin Hcl	135	38
Atenolol	Atenolol	131	31
Ezetimibe	Ezetimibe	128	27
Pantoprazole Sodium	Pantoprazole Sodium	125	37
Oxybutynin Chloride Er	Oxybutynin Chloride	119	27
Tramadol Hcl	Tramadol Hcl	118	27
Montelukast Sodium	Montelukast Sodium	115	29
Meloxicam	Meloxicam	113	32
Bupropion Xl	Bupropion Hcl	111	26
Fluoxetine Hcl	Fluoxetine Hcl	98	26
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	94	20
Warfarin Sodium	Warfarin Sodium	94	27
Lovastatin	Lovastatin	87	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	84	19
Famotidine	Famotidine	81	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	18
Hydralazine Hcl	Hydralazine Hcl	70	18
Mounjaro	Tirzepatide	70	12
Propranolol Hcl	Propranolol Hcl	69	19
Venlafaxine Hcl Er	Venlafaxine Hcl	69	22
Tamsulosin Hcl	Tamsulosin Hcl	67	19
Quetiapine Fumarate	Quetiapine Fumarate	65	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	62	15
Zolpidem Tartrate	Zolpidem Tartrate	62	12
Hydroxyzine Hcl	Hydroxyzine Hcl	61	23
Cephalexin	Cephalexin	60	36
Finasteride	Finasteride	60	14
Celecoxib	Celecoxib	58	20
Januvia	Sitagliptin Phosphate	58	12
Nystatin	Nystatin	58	15
Spironolactone	Spironolactone	58	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	57	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	13
Tizanidine Hcl	Tizanidine Hcl	55	14
Carvedilol	Carvedilol	54	18
Clopidogrel	Clopidogrel Bisulfate	54	14
Donepezil Hcl	Donepezil Hcl	53	suppressed
Diclofenac Sodium	Diclofenac Sodium	52	29
Triamcinolone Acetonide	Triamcinolone Acetonide	51	29
Escitalopram Oxalate	Escitalopram Oxalate	49	15
Alprazolam	Alprazolam	48	16
Memantine Hcl	Memantine Hcl	47	suppressed
Ondansetron Odt	Ondansetron	46	13
Bumetanide	Bumetanide	45	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	11
Enalapril Maleate	Enalapril Maleate	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	14
Buspirone Hcl	Buspirone Hcl	43	14
Estradiol	Estradiol	42	19
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	11
Fosinopril Sodium	Fosinopril Sodium	36	suppressed
Glimepiride	Glimepiride	36	suppressed
Glipizide	Glipizide	36	suppressed
Synthroid	Levothyroxine Sodium	36	13
Memantine Hcl Er	Memantine Hcl	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	12
Arnuity Ellipta	Fluticasone Furoate	34	suppressed
Fenofibrate	Fenofibrate	34	suppressed
Lorazepam	Lorazepam	34	suppressed
Irbesartan	Irbesartan	33	suppressed
Klor-Con M20	Potassium Chloride	33	12
Propranolol Hcl Er	Propranolol Hcl	33	11
Rizatriptan	Rizatriptan Benzoate	32	suppressed
Sucralfate	Sucralfate	31	11
Benazepril Hcl	Benazepril Hcl	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Naproxen	Naproxen	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Telmisartan	Telmisartan	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	12
Clonazepam	Clonazepam	24	suppressed
Spiriva Handihaler	Tiotropium Bromide	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	suppressed
Prednisone	Prednisone	23	18
Topiramate	Topiramate	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Pen Needle	Pen Needle, Diabetic	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	13
Nitroglycerin	Nitroglycerin	20	17
Xarelto	Rivaroxaban	20	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Valsartan	Valsartan	19	suppressed
Digoxin	Digoxin	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Insulin Aspart Flexpen	Insulin Aspart	17	suppressed
Ketoconazole	Ketoconazole	17	11
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Mesalamine Er	Mesalamine	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Insulin Aspart	Insulin Aspart	11	suppressed
Methimazole	Methimazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error